Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allo-GPBMC to Allo-HSCT for Relapsed and Refractory Leukemia
NCT07297173Phase 1Recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in leukemia, sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoints: Graft-Versus-Host Disease at 2 years, Infections at 2 years and 1 more. Started Dec 2025; status: recruiting.
02
Conditions
leukemia
Beyond the preview
Go deeper on NCT07297173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07297173.